Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GX-H9 in adult growth hormone deficiency
KCT0001682Phase 2Recruiting
- Sponsor
- Genexine
- Start
- Jan 2015
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of eftansomatropin alfa in adult onset growth hormone deficiency (AGHD), sponsored by Genexine. Started Jan 2015; status: recruiting.
02
Drugs
eftansomatropin alfa
03
Conditions
adult onset growth hormone deficiency (AGHD)
Beyond the preview
Go deeper on KCT0001682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0001682.